FTC Hits Torii with Cease, Desist, and Surcharge Payment Order over Price-Fixing for Calvan

March 9, 2020
Japan’s Fair Trade Commission (FTC) on March 5 issued a cease and desist order and a surcharge payment order to Torii Pharmaceutical for violating the Antimonopoly Act by price-fixing with Nippon Chemiphar for the hypertension treatment Calvan Tablets (bevantolol). Nippon...read more